ISIS-9125

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameISIS-9125
Drug Alias NameIP-9125
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionIntercellular adhesion molecule-1 inhibitors
TargetsIntercellular adhesion molecule-1
Therapy Area/IndicationsRejection of organ transplantationInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A